A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations - results of a prematurely terminated study
10.1186/s13063-018-2702-8
Saved in:
Main Authors: | Kalimuddin S., Chan Y.F.Z., Phillips R., Ong S.P., Archuleta S., Lye D.C., Tan T.T., Low J.G.H. |
---|---|
Other Authors: | DUKE-NUS MEDICAL SCHOOL |
Format: | Article |
Published: |
BioMed Central Ltd.
2019
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/151728 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations: Study protocol for a phase IIB randomized controlled trial
by: Kalimuddin, S, et al.
Published: (2020) -
Vancomycin For Methicillin-Resistant Staphylococcus Aureus Biofilm Eradication Is Associated With The Emergence Of Heterogeneous Vancomycin Intermediate Staphylococcus Aureus
by: ANDY SETIAWAN, 040810321, et al.
Published: (2022) -
Vancomycin monotherapy vs. combination therapy for the treatment of persistent methicillinresistant staphylococcus aureus bacteremia
by: Seah, J., et al.
Published: (2014) -
Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal beta-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia A Randomized Clinical Trial
by: Tong, Steven YC, et al.
Published: (2022) -
An association between bacterial genotype combined with a high-vancomycin minimum inhibitory concentration and risk of endocarditis in methicillin-resistant staphylococcus aureus bloodstream infection
by: Clare E. Miller, et al.
Published: (2018)